Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Wessely

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|June 2, 2021
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment ResistanceAnja Wessely, Theresa Steeb, Carola Berking, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2020
Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology groupAnja Wessely, Theresa Steeb, Carola Berking, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 16, 2024
Efficacy of interventions for cutaneous squamous cell carcinoma in situ (Bowen's disease): A systematic review and meta-analysis of proportionsAnne Petzold, Anja Wessely, Theresa Steeb, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2018
How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanomaTheresa Steeb, Anja Wessely, Thomas Ruzicka, et al.
Acta Dermato-Venereologica|June 25, 2019
Skin Cancer Smartphone Applications for German-speaking Patients: Review and Content Analysis Using the Mobile App Rating ScaleTheresa Steeb, Anja Wessely, Lars E French, et al.
Scientific Reports|April 8, 2022
Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trialsTheresa Steeb, Anne Petzold, Annkathrin Hornung, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinomaAnne Petzold, Theresa Steeb, Anja Wessely, et al.
Expert Opinion on Drug Safety|April 9, 2021
Safety of topical interventions for the treatment of actinic keratosisElias A T Koch, Anja Wessely, Theresa Steeb, et al.
International Journal of Molecular Sciences|December 9, 2020
Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?Anja Wessely, Theresa Steeb, Ulrike Leiter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 30, 2023
Identifying biomarkers and novel therapeutic targets in uveal melanomaAnja Wessely, Elias A T Koch, Julio Vera, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|June 2, 2021
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment ResistanceAnja Wessely, Theresa Steeb, Carola Berking, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2020
Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology groupAnja Wessely, Theresa Steeb, Carola Berking, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 16, 2024
Efficacy of interventions for cutaneous squamous cell carcinoma in situ (Bowen's disease): A systematic review and meta-analysis of proportionsAnne Petzold, Anja Wessely, Theresa Steeb, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2018
How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanomaTheresa Steeb, Anja Wessely, Thomas Ruzicka, et al.
Acta Dermato-Venereologica|June 25, 2019
Skin Cancer Smartphone Applications for German-speaking Patients: Review and Content Analysis Using the Mobile App Rating ScaleTheresa Steeb, Anja Wessely, Lars E French, et al.
Scientific Reports|April 8, 2022
Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trialsTheresa Steeb, Anne Petzold, Annkathrin Hornung, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinomaAnne Petzold, Theresa Steeb, Anja Wessely, et al.
Expert Opinion on Drug Safety|April 9, 2021
Safety of topical interventions for the treatment of actinic keratosisElias A T Koch, Anja Wessely, Theresa Steeb, et al.
International Journal of Molecular Sciences|December 9, 2020
Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?Anja Wessely, Theresa Steeb, Ulrike Leiter, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 30, 2023
Identifying biomarkers and novel therapeutic targets in uveal melanomaAnja Wessely, Elias A T Koch, Julio Vera, et al.
Pageof 6